Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Hot Topics
    • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Researchers Behind the Journals: Researcher Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Association for Cancer Research

American Association for Cancer Research

Advanced Search

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Hot Topics
    • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Researchers Behind the Journals: Researcher Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • Visit AACR on Facebook
  • Follow AACR on Twitter
  • Visit AACR on LinkedIn
  • Visit AACR on YouTube

Researcher Bio Jason J. Luke

Researchers Behind the Journals: Researcher Profile

Jason J. Luke

Clinical Cancer Research Senior Editor

Author Profile: Jason J. Luke

Dr. Jason J. Luke recently joined the editorial board of Clinical Cancer Research as a Senior Editor. He is an Associate Professor of Medicine and Director of the Cancer Immunotherapeutics Center at the University of Pittsburgh Medical Center’s Hillman Cancer Center. Dr. Luke specializes in both the management of patients with melanoma and early phase drug development.

As a lead national investigator on a number of clinical trials of immunotherapy agents, Dr. Luke’s major translational research is focused on using large scale informatics to advance the field of cancer immunotherapy. He received his medical doctorate from Rosalind Franklin University of Medicine and Science in Chicago, and afterwards pursued internship and residency at the Boston University Medical Center and fellowships at Weill Cornell Medical College and Memorial Sloan-Kettering Cancer Center.

In addition to his editorial work for Clinical Cancer Research, Dr. Luke has been an active member of the AACR since 2012. Dr. Luke was the chairperson of a minisymposium entitled “Hitting the Target Harder: Preclinical Development of Potent and Selective Inhibitors” in 2016 and has presented his work at various AACR conferences, with his most recent presentation on the topic of molecular correlates of the non-T cell-inflamed tumor microenvironment at the 2019 AACR-AHNS Head and Neck Cancer Conference in Austin, Texas.

In 2018, Dr. Luke received the Humanitarian Award from the Melanoma Research Foundation and the NCI Cancer Clinical Investigator Team Leadership Award.

Recent AACR Publications:

  • Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)
    Luke JJ…Schwartz GK. Clinical Cancer Research 2019 [Epub ahead of print].
  • WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
    Luke JJ…Gajewski TF. Clinical Cancer Research May 2019.
  • Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis
    Labadie B…Luke JJ. Clinical Cancer Research October 2018.
  • T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
    Trujillo JA…Luke JJ. Cancer Immunology Research September 2018.

Back to top


American Association for Cancer Research
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9354  |  E-mail:  pubs@aacr.org

  • Home
  • Alerts
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Article Collections

  • Focus Selections
  • "Best of" Collection

Info for:

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

AACR Journals

  • About AACR Journals
  • 3rd Party Permissions & Reprints
AACR logo

Copyright © 2019 by the American Association for Cancer Research.